Paracentesis for malignant ascites is usually performed as an in-patient procedure, with a median length of stay (LoS) of 3–5 days, with intermittent clamping of the drain due to a perceived risk of ...

Paracentesis is the standard treatment for refractory ascites in patients with cirrhosis, but it cannot prevent the recurrence of ascites. The placement of a transjugular intrahepatic portosystemic ...

Please provide your email address to receive an email when new articles are posted on . HONOLULU — Researchers found that patients with spontaneous bacterial peritonitis who underwent repeat ...

Please provide your email address to receive an email when new articles are posted on . A new low-flow ascites pump significantly reduced paracentesis frequency in patients with a contraindication to ...

HealthDay News— Aflibercept, a potent inhibitor of vascular endothelial growth factor (VEGF), shows clinical activity and increases the time to repeat paracentesis for patients with advanced ...

The Ascites may be due to cancer like ovarian malignancy. Cirrhosis of liver is the most common cause and the underlying liver disease is to be addressed first. The patient has to be counselled to ...

Aug. 23, 2004 — Large-volume paracentesis performed by gastrointestinal endoscopy assistants in an outpatient setting is safe and efficient, even in patients with marked thrombocytopenia or prolonged ...

Association between a validated symptom assessment tool and nurse clinical impression in patients with cancer admitted to a palliative care unit. This is an ASCO Meeting Abstract from the 2011 ASCO ...

NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Martin Pharmaceuticals, a clinical-stage pharmaceutical company targeting complications of advanced liver disease, today announced that results from its DREAM ...

The sponsor submitted a new cost analysis based on a decision tree model with an embedded Markov model. This model evaluated the costs per patient and system impact of the PeritX peritoneal catheter ...